Cargando…
Retraction: Glioma-Derived ADAM10 Induces Regulatory B Cells to Suppress CD8(+) T Cells
Autores principales: | Ye, Zhuo-peng, He, Hai-yong, Wang, Hui, Li, Wen-sheng, Luo, Lun, Huang, Zhen-chao, Guo, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979147/ https://www.ncbi.nlm.nih.gov/pubmed/33740011 http://dx.doi.org/10.1371/journal.pone.0249104 |
Ejemplares similares
-
Glioma-Derived ADAM10 Induces Regulatory B Cells to Suppress CD8(+) T Cells
por: Ye, Zhuo-peng, et al.
Publicado: (2014) -
miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma
por: Liu, Yahui, et al.
Publicado: (2022) -
Retraction: BRMS1 Suppresses Glioma Progression by Regulating Invasion, Migration and Adhesion of Glioma Cells
Publicado: (2022) -
Retracted: Downregulation of ADAM10 Expression Inhibits Metastasis and Invasiveness of Human Hepatocellular Carcinoma HepG2 Cells
por: BioMed Research International,
Publicado: (2014) -
Retracted: ADAM8 Activates NLRP3 Inflammasome to Promote Cerebral Ischemia-Reperfusion Injury
por: Healthcare Engineering, Journal of
Publicado: (2023)